Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults-Reply
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:331 |
|---|---|
| Enthalten in: |
JAMA - 331(2024), 8 vom: 27. Feb., Seite 709-710 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Qian, Edward T [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
157044-21-8 |
|---|
| Anmerkungen: |
Date Completed 28.02.2024 Date Revised 29.02.2024 published: Print CommentOn: JAMA. 2024 Feb 27;331(8):708. - PMID 38411649 Citation Status MEDLINE |
|---|
| doi: |
10.1001/jama.2023.27891 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369016068 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369016068 | ||
| 003 | DE-627 | ||
| 005 | 20240229235310.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jama.2023.27891 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1311.xml |
| 035 | |a (DE-627)NLM369016068 | ||
| 035 | |a (NLM)38411646 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Qian, Edward T |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults-Reply |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.02.2024 | ||
| 500 | |a Date Revised 29.02.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: JAMA. 2024 Feb 27;331(8):708. - PMID 38411649 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Cefepime |2 NLM | |
| 650 | 7 | |a 807PW4VQE3 |2 NLM | |
| 650 | 7 | |a Piperacillin, Tazobactam Drug Combination |2 NLM | |
| 650 | 7 | |a 157044-21-8 |2 NLM | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 700 | 1 | |a Semler, Matthew W |e verfasserin |4 aut | |
| 700 | 1 | |a Rice, Todd W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA |d 1948 |g 331(2024), 8 vom: 27. Feb., Seite 709-710 |w (DE-627)NLM000006939 |x 1538-3598 |7 nnns |
| 773 | 1 | 8 | |g volume:331 |g year:2024 |g number:8 |g day:27 |g month:02 |g pages:709-710 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jama.2023.27891 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 331 |j 2024 |e 8 |b 27 |c 02 |h 709-710 | ||